DEFA14A ·Filed Apr 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor next 10-Q for guidance revision
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$34.93
T+0 close · Apr 22, 2026 · via day close
Latest settled
−20.76%
T+60 · $27.68
Vs SPY
−25.77%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 23 $34.93entry
- T+1 · 7mo ago −2.58%α −3.36% · $34.03
- T+5 · 7mo ago −7.19%α −8.66% · $32.42
- T+20 · 6mo ago −13.27%α −17.90% · $30.30
- T+60 · 4mo ago −20.76%α −25.77% · $27.68
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Stoke Therapeutics' 2026 proxy statement details the election of three Class I directors, ratification of auditors, and advisory approval of executive compensation. This filing is routine governance material, routine for a biotech company.
Key Financial Metrics
Vote
director election
Meeting
2026-06-03
Seats Contested
3
Key Facts
- Election of Class I directors: G. Clare Kahn, Ph.D., Adrian Krainer, Ph.D., and Julie Anne Smith
- Ratification of Ernst & Young LLP as independent auditors for fiscal year 2026
- Advisory vote on executive compensation
Financial Impact
Routine governance matters with no immediate financial impact
governanceexecutive compensation
Risk Factors
- Potential for shareholder dissent on executive compensation
- Board composition changes could affect strategic direction
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-170393 |
| Document: 0001193125-26-170393-index-headers.html | 0001193125-26-170393 |
| Document: 0001193125-26-170393-index.html | 0001193125-26-170393 |
| Document: 0001193125-26-170393.txt | 0001193125-26-170393 |
Track record
18 reports on STOK
3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +17.49% at T+60 after the Aug 3, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $26.63 Now $26.63 −0.00% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $27.02 Now $26.63 −1.44% settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $26.84 Now $26.63 −0.78% settles Feb 12
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $26.12 Now $26.63 +1.95% settles Feb 12
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $26.07 Now $26.63 +2.15% settles Feb 3
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $26.29 Now $26.63 +1.29% settles Jan 28
- Oct 21, 202626d ago 144 Bearish 6/10 Entry $25.70 Now $26.63 −3.62% settles Jan 20
- Sep 30, 20266w ago SC 13G Neutral 4/10 Entry $26.01 Now $26.63 +2.38% settles Dec 28
- Sep 25, 20267w ago 8-K Neutral 2/10 Entry $25.50 Now $26.63 +4.43% settles Dec 22
- Aug 18, 202612w ago Insider Cluster Neutral 3/10 Entry $33.03 to $26.20 Now $26.63 −19.38% ▼ −20.68% −19.13% vs SPY
Showing 10 of 18
US Market Status
Market Closed · Opens in 9h 21m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers